Literature DB >> 20482436

Practical limitations of prescribing olanzapine depot (Relprevv).

Peter Devadason.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482436     DOI: 10.3109/10398561003733912

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


× No keyword cloud information.
  3 in total

1.  An evaluation of the use of olanzapine pamoate depot injection in seriously violent men with schizophrenia in a UK high-security hospital.

Authors:  Nina Baruch; Mrigendra Das; Amit Sharda; Amlan Basu; Tom Bajorek; Callum C Ross; Samrat Sengupta; Fintan Larkin; Susan Young
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

2.  Evaluation of olanzapine pamoate depot in seriously violent males with schizophrenia in the community.

Authors:  John Kasinathan; Gillian Sharp; Anthony Barker
Journal:  Ther Adv Psychopharmacol       Date:  2016-08-08

3.  Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years' experience at a UK high-secure hospital.

Authors:  Azizah Attard; John Wakelam; Josephine Broyd; David Taylor; Jonathan Hafferty
Journal:  Ther Adv Psychopharmacol       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.